EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc, a company founded in 1990 and based in Cardiff, United Kingdom, operates as an international supplier of diagnostic solutions. The firm excels in the development, manufacturing, and distribution of a wide array of diagnostic instruments, chemical reagents, and associated products. Its…
1D
+1.6%
1W
-3.8%
1M
+0.0%
6M
+2.0%
YTD
-5.3%
1Y
-10.9%
2Y
-16.1%
5Y
-69.1%
10Y
+47.1%
Next earnings date
30/03/2027 (in 164 days)
Volatility around earnings
~2% weaker price swings than usual
P/E
43.1
P/B
1.53
EV/EBITDA
7.53
RETURN ON EQUITY
3.3%
NET MARGIN
9.3%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
82.3%
FLOAT SHARES
352,217,267
AVG. DAILY VOLUME (30D)
559,302
EKF Diagnostics Holdings plc is a company in the Healthcare sector, Medical - Devices industry, headquartered in United Kingdom.
The CEO is Gavin Joseph Jones, the company employs around 308 people.
The IPO was on 04/01/2000; the stock trades on LSE under the ticker EKF.L.
The next earnings date is 30/03/2027.
Around past earnings, price swings were roughly -2% stronger than usual.
Yes. The last dividend was £1.20 per share, ex-date 02/11/2023, paid on 01/12/2023.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include Smith & Nephew, LivaNova, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and Siemens Healthineers.
Clicking "Analyze stock" lets five strategies assess EKF Diagnostics Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.